|
US7820422B2
(en)
|
2005-06-16 |
2010-10-26 |
Centre National De La Recherche Scientifique (Cnrs) |
Efficient production of oligosaccharides using metabolically engineered microorganisms
|
|
US20070202578A1
(en)
*
|
2005-08-26 |
2007-08-30 |
Centre National De La Recherche Scientifique (Cnrs) |
Production of globosides oligosaccharides using metabolically engineered microorganisms
|
|
BRPI0923433B1
(pt)
|
2008-12-19 |
2021-06-01 |
Jennewein Biotechnologie Gmbh |
Método para produzir uma célula geneticamente modificada tendo a capacidade de produzir compostos fucosilados e método para fazer um composto fucosilado
|
|
DK3235907T5
(da)
*
|
2010-07-12 |
2024-10-14 |
Inbiose Nv |
Metabolisk modificerede organismer til produktion af bioprodukter med merværdi
|
|
AU2011323288B2
(en)
*
|
2010-11-03 |
2016-05-26 |
Corbion Biotech, Inc. |
Microbial oils with lowered pour points, dielectric fluids produced therefrom, and related methods
|
|
US9816107B2
(en)
|
2011-07-29 |
2017-11-14 |
The University Of Wyoming |
Transgenic insect cells comprising a bacterial GlcNAc-6-P 2′-epimerase
|
|
US8846373B2
(en)
|
2011-07-29 |
2014-09-30 |
The University Of Wyoming |
Methods of using a bacterial GlcNAc-6-P 2′- epimerase to promote sialylation of glycoconjugates
|
|
WO2014048439A1
(en)
*
|
2012-09-25 |
2014-04-03 |
Glycom A/S |
Glycoconjugate synthesis
|
|
WO2014135167A1
(en)
*
|
2013-03-08 |
2014-09-12 |
Glycom A/S |
Purification of oligosaccaharides by reversible derivatization
|
|
HUE060672T2
(hu)
|
2013-03-14 |
2023-04-28 |
Glycosyn LLC |
Mikroorganizmusok és eljárások szialilált és N-acetilglükózamint tartalmazó oligoszacharidok elõállítására
|
|
US20160113952A1
(en)
|
2013-05-22 |
2016-04-28 |
Glycom As |
Synthetic Mixture of Oligosaccharides for Treating a Microbiota of a Mammal
|
|
CN104342469B
(zh)
*
|
2013-08-01 |
2017-06-30 |
东北师范大学 |
一种生物转化制备单唾液酸四己糖神经节苷脂的方法
|
|
WO2015032413A1
(en)
*
|
2013-09-06 |
2015-03-12 |
Glycom A/S |
Fermentative production of oligosaccharides
|
|
CN103602627B
(zh)
*
|
2013-11-25 |
2015-03-18 |
武汉中科光谷绿色生物技术有限公司 |
一种产n-乙酰神经氨酸大肠杆菌工程菌及其构建方法和应用
|
|
CN113684233B
(zh)
|
2014-06-27 |
2024-11-29 |
格礼卡姆股份公司 |
寡糖的制备
|
|
US11926858B2
(en)
|
2014-06-27 |
2024-03-12 |
Glycom A/S |
Oligosaccharide production
|
|
US9616114B1
(en)
|
2014-09-18 |
2017-04-11 |
David Gordon Bermudes |
Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
|
|
WO2016063262A1
(en)
|
2014-10-24 |
2016-04-28 |
Glycom A/S |
MIXTURES OF HMOs
|
|
US11040049B2
(en)
|
2014-10-29 |
2021-06-22 |
Glycom A/S |
Composition comprising HMSs/HMOs and use thereof
|
|
US11040050B2
(en)
|
2014-10-29 |
2021-06-22 |
Glycom A/S |
Composition comprising HMSs/HMOs and use thereof
|
|
PL3212198T3
(pl)
|
2014-10-29 |
2021-08-23 |
Glycom A/S |
Syntetyczna kompozycja i sposób promowania gojenia się błony śluzowej
|
|
WO2016066175A1
(en)
|
2014-10-29 |
2016-05-06 |
Glycom A/S |
Synthetic composition and method for treating irritable bowel syndrome
|
|
BR112017006295B1
(pt)
*
|
2014-11-14 |
2023-10-17 |
Inbiose N.V |
Método para a produção de microrganismos mutantes resistentes à morte por lactose, microrganismo e usos do mesmo
|
|
CN107106584A
(zh)
|
2014-12-08 |
2017-08-29 |
格礼卡姆股份公司 |
用于治疗代谢障碍的合成组合物
|
|
US10987368B2
(en)
|
2014-12-08 |
2021-04-27 |
Glycom A/S |
Synthetic composition for preventing or treating CVD
|
|
US10881674B2
(en)
|
2014-12-08 |
2021-01-05 |
Glycom A/S |
Synthetic composition for treating metabolic disorders
|
|
US10835544B2
(en)
|
2014-12-08 |
2020-11-17 |
Glycom A/S |
Synthetic composition for regulating satiety
|
|
PL3277287T3
(pl)
|
2015-03-31 |
2024-04-22 |
Glycom A/S |
Mieszaniny oligosacharydów mleka ludzkiego zawierające 3'-O-sialilolaktozę
|
|
US10676723B2
(en)
|
2015-05-11 |
2020-06-09 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
|
PL3307752T3
(pl)
|
2015-06-09 |
2021-11-02 |
Glycom A/S |
Mieszaniny trójskładnikowe 6’-sl, lnnt i lst c
|
|
EP3141610A1
(en)
|
2015-09-12 |
2017-03-15 |
Jennewein Biotechnologie GmbH |
Production of human milk oligosaccharides in microbial hosts with engineered import / export
|
|
US10751354B2
(en)
|
2015-09-14 |
2020-08-25 |
Glycom A/S |
Synthetic composition for microbiota modulation
|
|
US10780103B2
(en)
|
2015-10-28 |
2020-09-22 |
Glycom A/S |
Synthetic composition and method for modulating emotion and mood disorders
|
|
US10835545B2
(en)
|
2015-10-28 |
2020-11-17 |
Glycom A/S |
Synthetic composition and method for modulating brain function and behaviour
|
|
PL3377071T3
(pl)
|
2015-11-17 |
2024-06-24 |
Glycom A/S |
Oligosacharydy mleka ludzkiego do leczenia powikłań związanych z antybiotykami
|
|
CA3006400A1
(en)
*
|
2015-11-30 |
2017-06-08 |
Limmatech Biologics Ag |
Methods of producing glycosylated proteins
|
|
EP3389404B1
(en)
|
2015-12-15 |
2019-10-02 |
Société des Produits Nestlé S.A. |
Mixture of hmos
|
|
WO2017101958A1
(en)
|
2015-12-18 |
2017-06-22 |
Glycom A/S |
Fermentative production of oligosaccharides
|
|
WO2017144062A1
(en)
|
2016-02-24 |
2017-08-31 |
Glycom A/S |
Synthetic composition for microbiota modulation
|
|
ES2991621T3
(es)
|
2016-03-07 |
2024-12-04 |
Glycom As |
Separación de oligosacáridos de caldo de fermentación
|
|
WO2017190755A1
(en)
|
2016-05-05 |
2017-11-09 |
Glycom A/S |
Composition comprising hmos for use in the treatment of mast cell mediated visceral hypersensitivity and/or pain
|
|
PL3452050T3
(pl)
|
2016-05-05 |
2023-06-12 |
Glycom A/S |
Kompozycja zawierająca hmo do leczenia biegunki niezakaźnej
|
|
WO2017198276A1
(en)
|
2016-05-19 |
2017-11-23 |
Glycom A/S |
Synthetic composition
|
|
EP3474861A4
(en)
|
2016-06-24 |
2020-04-15 |
Glycom A/S |
COMPOUNDS COMPRISING HMOS FOR THE PREVENTION AND / OR TREATMENT OF VIRAL AND / OR BACTERIAL INFECTIONS.
|
|
US11129906B1
(en)
|
2016-12-07 |
2021-09-28 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
|
US11180535B1
(en)
|
2016-12-07 |
2021-11-23 |
David Gordon Bermudes |
Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
|
|
RU2019117393A
(ru)
*
|
2016-12-27 |
2020-12-07 |
Инбиоз Н.В. |
Синтез сиалированных соединений in vivo
|
|
US11278558B2
(en)
|
2017-03-01 |
2022-03-22 |
Glycom A/S |
Synthetic composition for microbiota modulation
|
|
US11291677B2
(en)
|
2017-05-09 |
2022-04-05 |
Glycom A/S |
Synthetic composition for microbiota modulation
|
|
US11541068B2
(en)
|
2017-05-24 |
2023-01-03 |
Glycom A/S |
HMO compositions and methods for reducing autism spectrum disorder symptoms
|
|
EP3630123A4
(en)
|
2017-05-24 |
2020-10-28 |
Glycom A/S |
SYNTHETIC COMPOSITION CONSISTING OF ONE OR MORE HUMAN MILK OLIGOSACCHARIDES (HMOS)
|
|
US11214588B2
(en)
|
2017-06-30 |
2022-01-04 |
Glycom A/S |
Synthesis of oligosaccharides
|
|
CN119655445A
(zh)
|
2017-07-12 |
2025-03-21 |
格礼卡姆股份公司 |
包含中性单糖或寡糖和酸性非碳水化合物组分的无定形混合物
|
|
US20210087599A1
(en)
|
2017-07-26 |
2021-03-25 |
Jennewein Biotechnologie Gmbh |
Sialyltransferases and their use in producing sialylated oligosaccharides
|
|
EP3672600A4
(en)
|
2017-08-21 |
2021-05-19 |
Glycom A/S |
SYNTHETIC COMPOSITION TO REDUCE ALLERGY SYMPTOMS
|
|
EP3456836A1
(en)
|
2017-09-13 |
2019-03-20 |
Glycom A/S |
Separation of sialylated oligosaccharides from fermentation broth
|
|
CA3076920A1
(en)
|
2017-10-04 |
2019-04-11 |
The Regents Of The University Of California |
Immunomodulatory oligosaccharides
|
|
CN111526879A
(zh)
|
2017-11-02 |
2020-08-11 |
格礼卡姆股份公司 |
用于减少或预防疲劳和/或改善注意力或专注力的一种或多种hmo
|
|
JP7327724B2
(ja)
|
2017-11-30 |
2023-08-16 |
グリコム・アクティーゼルスカブ |
小麦過敏症を処置するためのhmoの混合物
|
|
WO2019111115A2
(en)
|
2017-12-05 |
2019-06-13 |
Glycom A/S |
Human milk oligosaccharides for treating migraine
|
|
EP3724344A4
(en)
*
|
2017-12-15 |
2021-11-24 |
Glycosyn LLC |
SIALYLTRANSFERASES AND USES OF THEM
|
|
CN111683666A
(zh)
|
2017-12-22 |
2020-09-18 |
格礼卡姆股份公司 |
预防或减少伤害感受的包含hmo的组合物
|
|
GB2573539A
(en)
|
2018-05-09 |
2019-11-13 |
Mjn Us Holdings Llc |
Wellbeing supplement for postpartum maternal nutrition
|
|
EP3575404B1
(en)
|
2018-05-28 |
2022-10-19 |
Chr. Hansen HMO GmbH |
Fermentative production of sialylated saccharides
|
|
EP3801558A4
(en)
|
2018-05-31 |
2022-03-09 |
Glycom A/S |
HMOS BLEND FOR THE TREATMENT OF AUTOIMMUNE DISEASES
|
|
FI3801037T3
(fi)
*
|
2018-06-01 |
2023-01-13 |
|
Yksinkertainen menetelmä sialylaktooinin puhdistamiseen
|
|
CN113166789B
(zh)
*
|
2018-12-04 |
2025-03-28 |
格礼卡姆股份公司 |
岩藻糖基化寡糖lnfp-v的合成
|
|
US12233079B2
(en)
|
2018-12-19 |
2025-02-25 |
Glycom A/S |
Composition and method for treating humans using low-fodmap diets
|
|
CN109852651B
(zh)
*
|
2018-12-27 |
2022-03-15 |
大连大学 |
一种重组大肠杆菌质周腔内生产唾液酸修饰n-糖基化重组蛋白方法
|
|
CN110195043A
(zh)
*
|
2019-05-15 |
2019-09-03 |
武汉格莱利生物科技有限公司 |
一种高水溶性的cgta酶及其制备方法和应用
|
|
EP3789495A1
(en)
*
|
2019-09-03 |
2021-03-10 |
Jennewein Biotechnologie GmbH |
Production of sialylated oligosaccharides in bacillus cells
|
|
WO2021081670A1
(en)
*
|
2019-11-01 |
2021-05-06 |
The University Of British Columbia |
Compositions and methods for sialylated mucin-type o-glycosylation of therapeutic proteins
|
|
WO2021094133A2
(en)
|
2019-11-13 |
2021-05-20 |
Basf Se |
Enzymatic hydrolysis of 2',3-difucosyllactose
|
|
JP7833397B2
(ja)
|
2019-11-29 |
2026-03-19 |
グリコム・アクティーゼルスカブ |
妊婦の細菌叢を改善するためのhmoの混合物
|
|
US20230212628A1
(en)
*
|
2019-12-18 |
2023-07-06 |
Inbiose N.V. |
Production of Sialylated Oligosaccharide in Host Cells
|
|
BR112022011788A2
(pt)
*
|
2019-12-19 |
2022-08-30 |
Glycom As |
Separação de oligosacarídeos sialilados de caldo de fermentação
|
|
EP3848471A1
(en)
*
|
2020-01-10 |
2021-07-14 |
Chr. Hansen HMO GmbH |
Sequential fermentative production of oligosaccharides
|
|
WO2021170621A1
(en)
|
2020-02-24 |
2021-09-02 |
Carbocode S.A. |
Synthesis of c-glycosides of interest
|
|
CN115175915A
(zh)
*
|
2020-02-24 |
2022-10-11 |
碳码股份公司 |
糖基氟化物的合成
|
|
US20230094369A1
(en)
|
2020-02-24 |
2023-03-30 |
Carbocode S.A. |
Synthesis of glycosylated sphingoid bases of interest or analogues thereof
|
|
CN111500660A
(zh)
*
|
2020-04-23 |
2020-08-07 |
武汉糖智药业有限公司 |
一种单唾液酸四己糖神经节苷脂的合成方法
|
|
EP3954778B1
(en)
|
2020-08-10 |
2023-10-04 |
Inbiose N.V. |
Production of a mixture of neutral non-fucosylated oligosaccharides by a cell
|
|
EP3954769A1
(en)
*
|
2020-08-10 |
2022-02-16 |
Inbiose N.V. |
Production of oligosaccharide mixtures by a cell
|
|
FR3110176B1
(fr)
|
2020-05-12 |
2022-05-13 |
Institut Nat Des Sciences Appliquees De Toulouse |
Souche et procédé de production d’oligosaccharides
|
|
CN116472346A
(zh)
*
|
2020-08-10 |
2023-07-21 |
因比奥斯公司 |
借由细胞的唾液酸化寡糖混合物的生产
|
|
US20250361477A1
(en)
|
2020-08-10 |
2025-11-27 |
Inbiose N.V. |
Production of an oligosaccharide mixture by a cell
|
|
WO2022118269A1
(en)
|
2020-12-04 |
2022-06-09 |
Glycom A/S |
Human milk oligosaccharides for use in supporting maturation or improvement of sleeping patterns
|
|
EP4263565A4
(en)
*
|
2020-12-18 |
2025-04-16 |
Glycom A/S |
SEPARATION OF CHARGED OLIGOSACCHARIDES
|
|
JP2024505126A
(ja)
|
2021-01-22 |
2024-02-05 |
グリコム・アクティーゼルスカブ |
シアル酸付加hmoの産生における新規の主要ファシリテータースーパーファミリー(mfs)タンパク質(fred)
|
|
EP4284843B1
(en)
|
2021-01-29 |
2025-08-20 |
Centre National de la Recherche Scientifique (CNRS) |
Novel sialosides and their use in therapy
|
|
DK181061B1
(en)
|
2021-03-12 |
2022-10-31 |
Glycom As |
Purification of sialooligosaccharides
|
|
KR20230170961A
(ko)
*
|
2021-04-16 |
2023-12-19 |
인바이오스 엔.브이. |
시알릴화 이당 및/또는 올리고당의 세포 생산
|
|
KR20240008322A
(ko)
|
2021-04-16 |
2024-01-18 |
인바이오스 엔.브이. |
발효 생산
|
|
WO2022223430A1
(en)
|
2021-04-19 |
2022-10-27 |
Dsm Ip Assets B.V. |
A composition of enzymes and human milk oligosaccharides
|
|
PH12023553158A1
(en)
|
2021-05-20 |
2024-03-11 |
Chr Hansen As |
Sequential fermentative production of oligosaccharides
|
|
WO2022263425A1
(en)
|
2021-06-15 |
2022-12-22 |
Dsm Ip Assets B.V. |
Separation of human milk oligosaccharides from a fermentation broth
|
|
EP4355465A1
(en)
|
2021-06-15 |
2024-04-24 |
DSM IP Assets B.V. |
Separation of human milk oligosaccharides from a fermentation broth
|
|
US20240286081A1
(en)
|
2021-06-15 |
2024-08-29 |
Dsm Ip Assets B.V. |
Separation of human milk oligosaccharides from a fermentation broth
|
|
BE1029434B1
(nl)
|
2021-06-15 |
2023-07-31 |
Dsm Ip Assets Bv |
Scheiding van moedermelkoligosachariden uit een fermentatiebouillon
|
|
WO2023097604A1
(zh)
*
|
2021-12-02 |
2023-06-08 |
岩唐生物科技(杭州)有限责任公司 |
分离的多肽及其应用
|
|
DK181683B1
(en)
|
2022-03-02 |
2024-09-20 |
Dsm Ip Assets Bv |
Cells exprssing new sialyltransferases for in vivo synthesis of lst-a, methods using same and constructs encoding said sialyltransferases
|
|
DK181319B1
(en)
|
2022-03-02 |
2023-08-10 |
Dsm Ip Assets Bv |
Genetically engineered cells and methods comprising use of a sialyltransferase for in vivo synthesis of 3’sl
|
|
CN118786221A
(zh)
|
2022-03-02 |
2024-10-15 |
帝斯曼知识产权资产管理有限公司 |
用于体内合成3'sl和6'sl的新型唾液酸转移酶
|
|
CN114965543B
(zh)
*
|
2022-06-13 |
2023-10-20 |
青岛科技大学 |
壳寡糖nmr波谱的归属及脱乙酰度相关指标的测定方法
|
|
DK182283B1
(en)
|
2022-06-20 |
2026-02-10 |
Dsm Ip Assets Bv |
Methods and cell comprising new sialyltransferases for in vivo synthesis of lst-c and use of the same
|
|
DK202200588A1
(en)
|
2022-06-20 |
2024-02-23 |
Dsm Ip Assets Bv |
Mixture of fucosylated HMOs
|
|
CN115094103A
(zh)
*
|
2022-07-22 |
2022-09-23 |
南宁东恒华道生物科技有限责任公司 |
以蔗糖、淀粉或糖原为原料组合酶法生产半乳糖的新工艺
|
|
CN115820594B
(zh)
*
|
2022-12-27 |
2026-04-21 |
中国科学院海洋研究所 |
一种病毒来源的几丁质合成酶的表达纯化方法及其用途
|
|
CN117778345A
(zh)
*
|
2024-01-14 |
2024-03-29 |
北京睿脉医药科技有限公司 |
可固化和重复利用的幽门螺杆菌岩藻糖基转移酶突变体
|
|
CN119876092B
(zh)
*
|
2024-12-30 |
2025-10-31 |
嘉必优生物技术(武汉)股份有限公司 |
一种尿苷5′-二磷酸-n-乙酰氨基葡萄糖2差向异构酶的突变体及其应用
|